Did you know that the University of Hawaii Cancer Center is a beacon of hope? It stands as one of only 68 research organizations in the U.S. with the prestigious National Cancer Institute designation. This recognition signifies its place among the world’s best cancer research institutions.
Established in 1971, the University of Hawaii Cancer Center secured its NCI designation in 1996. The center’s core mission is clear. It aims to alleviate the burden of cancer. This is done through research, education, patient care, and community outreach. It emphasizes the unique ethnic, cultural, and environmental factors prevalent in Hawaii and the Pacific region.
The Hawaii Cancer Consortium is under the leadership of the UH Cancer Center. It unites major health systems and healthcare providers. These include Adventist Health Castle, Hawaii Medical Service Association, and Hawaii Pacific Health. They also include Kuakini Medical Center, The Queen’s Health Systems, and the UH John A. Burns School of Medicine. Together, they advance cancer research, education, and community outreach.
Located far out in the Pacific Ocean, the UH Cancer Center’s reach is unique. Its impact area includes Hawaii and the US-Affiliated Pacific Islands. This vast region faces distinctive cancer challenges. It also has profound health disparities. These factors drive the center’s research activities. These encompass basic, clinical, epidemiologic, and cancer prevention studies.
Significant disparities exist within Hawaii. Native Hawaiians are particularly affected. Research programs focus on ethnic diversity factors. These factors promote cancer health disparities. Specific cancers disproportionately affecting the population are studied. These include liver, thoracic, and breast cancer. Environmental factors that contribute to increased cancer incidence and mortality are also examined.
Researchers investigate the impact of smoking and e-cigarette use on cancer mortality. They also look at how diet and nutrition affect liver cancer risk. Additionally, they study the role of betel nut chewing in causing oral cancers. The UH Cancer Center provides international leadership in these areas.
The center has two main research programs. One focuses on population sciences. The other focuses on cancer biology. The Population Sciences in the Pacific Program studies behavioral and environmental factors. These are linked to cancer risk and patient survival. The Multiethnic Cohort Study has generated numerous publications. These publications relate to lifestyle, genetics, and cancer prevention.
The Cancer Biology Program focuses on cancer development and biomarkers. It also studies cell sites for interventions. The program addresses cancers prevalent in Hawaiian adults and children. It also addresses cancers linked to environmental exposures. Additionally, it explores natural products from local species. The goal is to discover compounds with anticancer properties.
Translational clinicians play a crucial role. They enroll individuals from minority groups in clinical trials. A significant portion of participants are Asian. Native Hawaiians also participate. The UH Cancer Center provides valuable knowledge about effective therapies for this group. Overall, a large percentage of clinical trial participants are from racial or ethnic minorities.
The University of Hawaii Cancer Center is developing an Early Phase Clinical Research Center. It is named Ho’ola. This pioneering facility will specialize in early-phase clinical trials. It will give Hawaii’s patients access to innovative treatments. The facility includes a clinical blood lab, infusion suites, a nursing station, and a research pharmacy. The UH Cancer Center is committed to reducing the burden of cancer. It strives to provide practical, inclusive, and innovative cancer care in Hawaii.